openPR Logo
Press release

MarketsandMarkets: U.S. Biopharmaceuticals Market Worth $144 billion by 2016

12-07-2010 09:50 AM CET | Health & Medicine

Press release from: MarketsandMarkets.com

BIOPHARMA analyzes the U.S. Biopharmaceuticals Market and its growth factors, with special emphasis on the top companies in the field and their product pipeline. The report also analyses the current trends and focus of the U.S. biopharmaceutical market and the challenges faced by the industry. It also provides profiles of the major companies participating in the United States market.

Browse market data tables and in-depth TOC on U.S. Biopharmaceutical Market - Trends, Forecast, Competition & Strategic Analysis (2009 - 2016)
Early buyers will receive 10% customization of reports.
http://www.marketsandmarkets.com/Market-Reports/biopharmaceutical-323.html

The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. This growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.

This research report analyzes the U.S. biopharmaceuticals market and its growth factors, with special emphasis on top companies in the field and their product pipeline. While it looks at the overall market size and presents forecast till 2016.

A key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has led to the metamorphosis of the pharmaceutical industry, resulting in the subset industry of biopharmaceuticals. The big players in the pharma industry, including Pfizer, Merck, and Novartis, have been the first few to reap the benefits of investing in biotechnology through both organic as well as inorganic growth mechanisms.

Market forecasts include the biopharmaceuticals currently in the market as well as those projected to enter the market by the end of the forecast period in 2016. Market challenges, drivers, and restraints have also been identified and assessed. Selected late stage pipeline analysis is also included.

This report analyzes the biopharmaceutical industry’s products, features, companies, market size and potential and patent portfolios. The impact of the Medicare and Medicaid policies and individual plan behaviors on the biopharmaceutical industry is also discussed.

Key Findings
• To define and measure the biopharmaceutical market in the U.S.
• To identify the major drivers, restraints, and opportunities in the biopharmaceutical market.
• To identify and analyze comprehensively the biopharmaceutical market structure with respect to the factors influencing market growth and industry-specific challenges.
• To analyze the trends and provide the forecasts for the biopharmaceutical market and its segments with respect to different geographies.
• To identify the major stakeholders in the biopharmaceutical market and draw a competitive landscape.
• To understand the regulatory framework, patient safety and pricing issues of the biopharmaceutical market.

Scope of the report

Market Overview
This section discusses the market definition of U.S. biopharmaceutical market. This section also discusses the way market is segmented and the methodology as well as the assumptions considered for forecasting the revenues for the all the individual product/drug class segments.

Market segmentation
This research service covers biopharmaceuticals and their impact on the U.S. healthcare market.

Products included in this study by their market segmentation:
• Gene and Cell therapies, including “Antisense Therapies”
• Cytokines
• PEH: Proteins, Enzymes, and Hormones
• Monoclonal Antibodies
• Vaccines
• Others: Blood and Allergenic components and others.

Products not included:
• Biosurgical products like tissue grafts and sealants
• Biologics used for diagnostic purposes
• Bionanotechnology drugs

Analysis Insights
This section discusses the current trends and focus of the U.S. biopharmaceutical market and the challenges faced by the industry. Other sections include market analysis, patent analysis and competitive landscape.

Company Profiles
This section provides the company profiles of major companies participating in the U.S. biopharmaceutical market. Company profiles include a brief overview of the company, primary business, strategies followed and developments.

Analyst Briefing Presentation on U.S. Biopharmaceutical Market - Trends, Forecast, Competition & Strategic Analysis (2009 - 2016) to be held on 14 Dec 2010

The CMF practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on U.S. Biopharmaceutical Market - Trends, Forecast, Competition & Strategic Analysis (2009 - 2016) to be held on 14 Dec 2010. The briefing will cover an analysis of trends and current focus of the U.S. biopharmaceutical market and the challenges faced by the industry. The impact of biopharmaceuticals on the U.S. healthcare market will also be discussed during the briefing.

To register for this briefing, please click here
http://www.marketsandmarkets.com/AnalystBriefing/biopharmaceutical.asp

About MarketsandMarkets
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategic advisory reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M Banking and Financial Services practice recognizes the challenges that financial institutions face bringing the right products to market. Our reports and consulting practice provide a unique perspective allowing the financial institution to see and experience the best way to achieve their product goals. Through a mix of case studies, primary research, and business modeling we provide a 360° view to identify how you can create, capture, and keep the value of your product and out think the competition.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com
http://www.marketsandmarkets.com

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategic advisory reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M Banking and Financial Services practice recognizes the challenges that financial institutions face bringing the right products to market. Our reports and consulting practice provide a unique perspective allowing the financial institution to see and experience the best way to achieve their product goals. Through a mix of case studies, primary research, and business modeling we provide a 360° view to identify how you can create, capture, and keep the value of your product and out think the competition.

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com
http://www.marketsandmarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MarketsandMarkets: U.S. Biopharmaceuticals Market Worth $144 billion by 2016 here

News-ID: 154447 • Views:

More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players are Sika (Switzerland), BASF (Germany), MAPEI (Italy), GCP Applied Technologies (US), CEMEX (Mexico), W. R. Meadows (US)
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any

All 5 Releases


More Releases for MarketsandMarkets

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
Automotive Engineering Services Market | MarketsandMarkets
Automotive engineering services deal with the design and development of automotive components and related technologies to address complex technical challenges in the vehicle development value chain. The engineering service process starts with conceptualization, designing, prototyping, system integration, and testing. Automotive engineering services include vehicle connectivity services, ADAS (advanced driver-assistance systems) and safety systems, interior & exterior design and body engineering services, passenger comfort, and others. These services assess different areas
Global Automotive Glass Market | MarketsandMarkets
The Automotive Glass Market is projected to grow at a CAGR of 4.80%, to reach a market size of $23.59 billion by 2025. The global market is driven by increasing vehicle production (especially in the SUV segment), upcoming smart glass & device embedded glass technologies, and increasing glass applications to improve the aesthetics of the car. The key players in the automotive glass market are Saint-Gobain (France), Asahi Glass (Japan), Fuyao
Rolling Stock Market (2021-2025) | MarketsandMarkets
The global Rolling Stock Market is estimated to be $51.6 billion in 2020 and is projected to reach $64.3 billion by 2025, growing at a CAGR of 4.5% from 2020 to 2025. Asia Oceania is estimated to lead the market in 2020; China, Japan, and India are the key contributors to the rolling stock market in the region. Increasing urbanization, adoption of public transport as a means of reducing traffic
Automotive Logistics Market | MarketsandMarkets
The Automotive Logistics Market is estimated to be $284.1 billion in 2018 and is projected to reach $472.9 billion by 2025, at a CAGR of 7.55%. Increasing vehicle production, upcoming infrastructure projects, and the advent of electric vehicles are the major reasons for market growth. The automotive logistics market is consolidated and dominated by a few global players. The key players in the market are DHL (Germany), XPO (US), SNCF (France),
Electric Bike Market 2020-2027 | MarketsandMarkets
The global E-Bike Market size is projected to grow to $70.0 billion by 2027 from $41.1 billion in 2020, at a CAGR of 7.9%. Government initiatives towards clean environment and technology advancements such as connected electric bikes are driving the market growth. The key players in the electric Bike industry are Accell Group N.V. (Netherlands), Pon. Bike (US), Merida Industry Co., Ltd. (Taiwan), Giant Manufacturing Co., Ltd. (Taiwan), and Yamaha